Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10-12, 08028 Barcelona, Spain.
3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Avepark, Zona Industrial da Gandra, 4805-017 Barco-Guimarães, Portugal.
Biofabrication. 2022 Sep 13;14(4). doi: 10.1088/1758-5090/ac8dc8.
Bioengineered human skeletal muscle tissues have emerged in the last years as newsystems for disease modeling. These bioartificial muscles are classically fabricated by encapsulating human myogenic precursor cells in a hydrogel scaffold that resembles the extracellular matrix. However, most of these hydrogels are derived from xenogenic sources, and the culture media is supplemented with animal serum, which could interfere in drug testing assays. On the contrary, xeno-free biomaterials and culture conditions in tissue engineering offer increased relevance for developing human disease models. In this work, we used human platelet lysate (PL)-based nanocomposite hydrogels (HUgel) as scaffolds for human skeletal muscle tissue engineering. These hydrogels consist of human PL reinforced with aldehyde-cellulose nanocrystals (a-CNC) that allow tunable mechanical, structural, and biochemical properties for the 3D culture of stem cells. Here, we developed hydrogel casting platforms to encapsulate human muscle satellite stem cells in HUgel. The a-CNC content was modulated to enhance matrix remodeling, uniaxial tension, and self-organization of the cells, resulting in the formation of highly aligned, long myotubes expressing sarcomeric proteins. Moreover, the bioengineered human muscles were subjected to electrical stimulation, and the exerted contractile forces were measured in a non-invasive manner. Overall, our results demonstrated that the bioengineered human skeletal muscles could be built in xeno-free cell culture platforms to assess tissue functionality, which is promising for drug development applications.
近年来,生物工程化的人类骨骼肌组织已经成为疾病建模的新系统。这些生物人工肌肉通常通过将人类成肌前体细胞包裹在类似于细胞外基质的水凝胶支架中来制备。然而,大多数这些水凝胶来源于异种来源,并且培养基中补充了动物血清,这可能会干扰药物测试分析。相比之下,组织工程中的无动物成分的生物材料和培养条件为开发人类疾病模型提供了更高的相关性。在这项工作中,我们使用基于人血小板裂解物(PL)的纳米复合水凝胶(HUgel)作为人类骨骼肌组织工程的支架。这些水凝胶由人 PL 增强的醛基纤维素纳米晶(a-CNC)组成,允许对干细胞的 3D 培养进行可调的机械、结构和生化特性的调节。在这里,我们开发了水凝胶浇铸平台,将人类肌肉卫星干细胞封装在 HUgel 中。调节 a-CNC 的含量以增强基质重塑、单轴拉伸和细胞的自组织,从而形成高度对齐的、表达肌节蛋白的长肌管。此外,对生物工程化的人类肌肉进行电刺激,并以非侵入性的方式测量所产生的收缩力。总的来说,我们的结果表明,可以在无动物成分的细胞培养平台上构建生物工程化的人类骨骼肌,以评估组织功能,这对于药物开发应用具有广阔的前景。